1.
Medicine Today. 2007; 5 (1): 28-30
em Inglês
| IMEMR
| ID: emr-84485
RESUMO
Interferon has remained the mainstay for treating patients suffering from chronic viral hepatitis. However, its efficiency has been limited by the neuropsychiatric side effect profile that it carries; neurotransmitter alterations in the central nervous system [CNS] have been correlated to psychiatric complications of Interferon alpha. Although mood disorders such as depression occasionally develop during Interferon alpha therapy, psychotic disorders have been rarely reported. We present a case of Interferon alpha 2b induced psychotic symptoms in a young male with hepatitis B and review the relevant literature